C-BCT

T:BCT - BRIACELL THERAPEUTICS CORP. J - https://www.briacell.com

10:58:26 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BCT - T	0.2	13.33	·	13.76	0.1	13.44	-0.83	-5.8	5.9	77	84	14.12 14.12 13.33	244.50 8.40	15:59:50	Dec 11	15 min RT 2¢
TSX - T	0.2	13.33	·	13.76	0.1	13.44	-0.83	-5.8	4.7	62	52	14.12 14.12 13.33	244.50 8.40	15:59:50		15 min
CSE ATS - P						14.27			0.06	1	2			Nov 25		15 min
CXC - X						13.87	-0.40	-2.8	0.1	1	1	13.87 13.87 13.87		12:49:01		15 min
CXD - D						14.27			0.1	2	9			Dec 10		15 min
MatchNOW - M						14.27			0.6	7	17			Sep 11-20		15 min
Lynx - Y						13.56	-0.71	-5.0	0.3	4	3	13.77 13.77 13.56		13:56:32		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 84

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:50	T	13.44	-0.83	100	80 National Bank	7 TD Sec	K
15:57:17	M	13.44	-0.83	90	80 National Bank	80 National Bank	E
15:53:59	M	13.43	-0.84	100	1 Anonymous	79 CIBC
15:53:59	T	13.44	-0.83	100	2 RBC	7 TD Sec	K
15:49:49	D	13.44	-0.83	30	124 Questrade	2 RBC	E
15:37:15	T	13.33	-0.94	100	79 CIBC	79 CIBC	K
15:37:15	T	13.35	-0.92	100	7 TD Sec	79 CIBC	K
15:37:15	T	13.35	-0.92	100	80 National Bank	79 CIBC	K
15:37:15	T	13.35	-0.92	100	80 National Bank	79 CIBC	K
15:37:15	T	13.35	-0.92	100	80 National Bank	79 CIBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-12-11 17:11	C:BCT	14.27	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-12-11 17:05	C:BCT	14.27	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-12-10 07:30	C:BCT	16.83	News Release200	BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS(TM) 2025
2025-12-09 16:43	C:BCT	16.83	News Release200	Briacell phase 3 enrolment on track for H1 2026 readout
2025-12-02 07:30	C:BCT	13.58	News Release200	BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS(TM) 2025
2025-11-25 07:30	C:BCT	11.97	News Release200	BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS(TM) 2025
2025-11-20 17:34	C:BCT	10.23	News Release200	Briacell, Receptor.AI to work on kinase inhibitors
2025-11-18 07:30	C:BCT	11.40	News Release200	BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS(TM) 2025
2025-11-07 12:39	C:BCT	13.98	News Release200	Briacell presents Bria-OTS+ preclinical results at SITC
2025-11-04 07:30	C:BCT	13.95	News Release200	BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+(TM) in Breast and Prostate Cancer Models
2025-10-22 16:51	C:BCT	16.97	News Release200	Briacell's Bria-IMT study receives no safety concerns
2025-10-21 16:27	C:BCT	17.77	News Release200	Briacell adds three sites to Bria-IMT phase 3 study
2025-10-21 15:52	C:BCT	17.08	News Release200	Briacell, MSK to work on Bria-OTS+ clinical development
2025-10-20 17:23	C:BCT	17.08	News Release200	Briacell presents phase 3 biomarker data at ESMO 2025
2025-10-15 19:35	C:BCT	16.50	SEDAR Annual Report803	SEDAR Annual Report
2025-10-15 19:29	C:BCT	16.50	SEDAR MD & A815	SEDAR MD & A
2025-10-15 19:18	C:BCT	16.50	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-10-13 07:30	C:BCT	17.18	News Release200	BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
2025-10-03 07:30	C:BCT	17.80	News Release200	BriaCell to Present Bria-OTS+(TM) Preclinical Data at SITC 2025 Annual Meeting
2025-08-26 16:30	C:BCT	11.46	News Release200	Briacell says MOA validated in cancer journal

Date ET

Symbol

Price

Type

Headline

2025-12-11 17:11

C:BCT

14.27

SEDAR Interim MD & A

2025-12-11 17:05

C:BCT

14.27